![Alan Au](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Au
Fondateur chez
GT Capital Investment Ltd.
Profil
Alan Au is the founder of GT Capital Investment Ltd. founded in 2013, where he holds the title of General Partner.
He currently holds positions as Director at G.I.
Windows, Inc. and Advisor at Oxford Investment Consultants LLP.
Mr. Au previously held the position of Board Member at Cellular Biomedicine Group (Shanghai) Ltd. from 2014 to 2021 and Board Member at I-MAB Biopharma Co., Ltd. Mr. Au received his undergraduate degree from The Chinese University of Hong Kong in 1994 and his MBA from Columbia Business School in 2007.
Postes actifs de Alan Au
| Sociétés | Poste | Début |
|---|---|---|
GT Capital Investment Ltd.
 GT Capital Investment Ltd. Investment ManagersFinance GT Healthcare Capital Partners is an active manager which invests in companies located in China (People's Republic). It participates in early stage transactions and focuses on sectors such as Health Technology and Health Services. | Fondateur | 01/01/2013 |
Oxford Investment Consultants LLP
 Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants invests in companies located in the United Kingdom. The firm focuses on companies operating in the life sciences, deep tech and physical sectors sectors. It participates in seed and early stage capital requirements. | Consultant / Advisor | - |
G.I. Windows, Inc.
 G.I. Windows, Inc. Medical SpecialtiesHealth Technology Manufactures surgical anastomotic systems | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan Au
| Sociétés | Poste | Fin |
|---|---|---|
Cellular Biomedicine Group (Shanghai) Ltd.
 Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Engages in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies | Directeur/Membre du Conseil | 01/02/2021 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Directeur/Membre du Conseil | - |
Formation de Alan Au
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
G.I. Windows, Inc.
G.I. Windows, Inc. Medical SpecialtiesHealth Technology Manufactures surgical anastomotic systems | Health Technology |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants invests in companies located in the United Kingdom. The firm focuses on companies operating in the life sciences, deep tech and physical sectors sectors. It participates in seed and early stage capital requirements. | Finance |
Cellular Biomedicine Group (Shanghai) Ltd.
Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Engages in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies | Health Technology |
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Healthcare Capital Partners is an active manager which invests in companies located in China (People's Republic). It participates in early stage transactions and focuses on sectors such as Health Technology and Health Services. | Finance |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
